Epidemiology of peripheral neuropathy and lower extremity disease in diabetes

CW Hicks, E Selvin - Current diabetes reports, 2019 - Springer
Abstract Purpose of Review Diabetic peripheral neuropathy eventually affects nearly 50% of
adults with diabetes during their lifetime and is associated with substantial morbidity …

A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the world workshop on oral …

A Wolff, RK Joshi, J Ekström, D Aframian… - Drugs in R&d, 2017 - Springer
Background Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation
of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of …

RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020Table. No title available.

R Chawla, SV Madhu, BM Makkar… - Indian journal of …, 2020 - journals.lww.com
Guidelines RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2
Diabetes Mellitus 2020Table. No title available.

Neuroplasticity underlying the comorbidity of pain and depression

L Doan, T Manders, J Wang - Neural plasticity, 2015 - Wiley Online Library
Acute pain induces depressed mood, and chronic pain is known to cause depression.
Depression, meanwhile, can also adversely affect pain behaviors ranging from …

Pain pathways and nervous system plasticity: learning and memory in pain

B McCarberg, J Peppin - Pain Medicine, 2019 - academic.oup.com
Objective This article reviews the structural and functional changes in pain chronification
and explores the association between memory and the development of chronic pain …

Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options

A Bondar, AR Popa, N Papanas… - Experimental and …, 2021 - spandidos-publications.com
Diabetic neuropathy (DN) is a frequent complication of diabetes mellitus (DM) with severe
consequences as it progresses and influences all human body systems. This review …

[HTML][HTML] Off-label uses of drugs for depression

SS Skånland, A Cieślar-Pobuda - European journal of pharmacology, 2019 - Elsevier
The prescription of drugs for depression is rising rapidly. One of the reasons for this trend is
their many off-label uses. Up to one third of all prescriptions are for non-indicated use, which …

A review of duloxetine 60 mg once‐daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to …

JV Pergolizzi Jr, RB Raffa, R Taylor Jr… - Pain …, 2013 - Wiley Online Library
Background: Duloxetine is a selective dual neuronal serotonin (5‐Hydroxytryptamine, 5‐HT)
and norepinephrine reuptake inhibitor (SSNRI). It is indicated in the United States for …

Suboptimal treatment of diabetic peripheral neuropathic pain in the United States

M Yang, C Qian, Y Liu - Pain Medicine, 2015 - academic.oup.com
Objective Approximately one third of patients with diabetic peripheral neuropathy (DPN) also
experience neuropathic pain, resulting in a significant health care burden, and reduced …

Changes in the central nervous system in diabetic neuropathy

Y Zang, D Jiang, X Zhuang, S Chen - Heliyon, 2023 - cell.com
One of the most common chronic complications arising from diabetes is diabetic peripheral
neuropathy. Depending on research statistics, approximately half of the people who have …